These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9839329)

  • 41. High-resolution scintimammography: a pilot study.
    Brem RF; Schoonjans JM; Kieper DA; Majewski S; Goodman S; Civelek C
    J Nucl Med; 2002 Jul; 43(7):909-15. PubMed ID: 12097461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Technetium-99m-tetrofosmin radionuclide mammography in the diagnosis of malignant breast tumors].
    Jauković L
    Vojnosanit Pregl; 2004; 61(1):35-40. PubMed ID: 15022387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of patient positioning in scintimammography.
    Mirzaei S
    Eur J Nucl Med; 2001 Jul; 28(7):941-2. PubMed ID: 11504096
    [No Abstract]   [Full Text] [Related]  

  • 45. Scintimammography in the diagnosis of breast cancer.
    Clifford EJ; Lugo-Zamudio C
    Am J Surg; 1996 Nov; 172(5):483-6. PubMed ID: 8942549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
    Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility and reproducibility of semiquantitative analysis of sestamibi breast images.
    Dunnwald LK; Hartnett SD; Mankoff DA
    J Nucl Med Technol; 1997 Jun; 25(2):106-9. PubMed ID: 9239613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
    Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
    Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol].
    Prats E; Abós M; Aisa F; Villavieja L; Asenjo M; García-López F; Tomás A; Sainz J; Razola P; Banzo J
    Rev Esp Med Nucl; 1998; 17(2):73-81. PubMed ID: 9611276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast parenchymal activity on scintimammography: comparison between bone-seeking agents and 99mTc-sestamibi.
    Inoue Y; Katayama N; Yoshioka N; Yoshikawa K; Kashima M; Shimizu T; Tsukune Y; Ohtomo K
    Ann Nucl Med; 1999 Dec; 13(6):453-6. PubMed ID: 10656284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
    Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
    Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography.
    Scopinaro F; Ierardi M; Porfiri LM; Tiberio NS; De Vincentis G; Mezi S; Cannas P; Gigliotti T; Marzetti L
    Anticancer Res; 1997; 17(3B):1635-8. PubMed ID: 9179209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The usefulness of Tc-99m sestamibi scintimammography in the diagnosis of squamous cell carcinoma of the breast.
    Ohta H; Saito T; Yamamoto S; Ukikusa M; Awane H; Shintaku M
    Clin Nucl Med; 1998 Sep; 23(9):617-8. PubMed ID: 9735988
    [No Abstract]   [Full Text] [Related]  

  • 56. Can reduced imaging times be used for scintimammography?
    Clarke EA; Notghi A; Harding LK
    Nucl Med Commun; 1999 Oct; 20(10):883-6. PubMed ID: 10528291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procedure guideline for breast scintigraphy. Society of Nuclear Medicine.
    Khalkhali I; Diggles LE; Taillefer R; Vandestreek PR; Peller PJ; Abdel-Nabi HH
    J Nucl Med; 1999 Jul; 40(7):1233-5. PubMed ID: 10405150
    [No Abstract]   [Full Text] [Related]  

  • 58. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
    Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
    Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scintimammography using Tc-99m tetrofosmin.
    Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
    Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The evaluation of combined scintimammography and tumor markers in breast cancer patients.
    Mangkharak J; Patanachak C; Podhisuwan K; Pleehachinda R
    Anticancer Res; 1997; 17(3B):1611-4. PubMed ID: 9179203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.